The nation of Zimbabwe has declined a substantial American healthcare agreement valued at 367 million US dollars (£272m) spanning five years because of Washington's insistence on sensitive data.
This rejection became public after a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa felt the arrangement was "unbalanced".
An official spokesperson has since clarified that the United States was seeking biological samples for scientific study and profit but was not willing to guarantee the benefits from any future medical innovations.
"We are forced to start the challenging and unfortunate process of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged continued talks to reach a agreement suitable to all parties so the country's critical HIV programme can be sustained.
Broader Implications
Zimbabwe's decision comes after a similar case in Kenya, where a high court suspended a similar health funding agreement after concerns were filed about the security of Kenyans' health data.
After resuming office recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump argued its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to boost openness and responsibility.
As per statements, Sixteen African countries have so far signed similar agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Deal
The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this cooperation might have yielded immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment through American-funded initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"Our nation was requested to provide its genetic material and health information for a long time, with no corresponding assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"In essence, our country would provide the basic resources for medical research without any assurance that the final treatments would be accessible to our citizens should a future disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one deals were upending frameworks previously established via the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to deal with potential pandemics.
"This mechanism is designed to ensure that when a nation provides its data, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome ongoing dialogue with our American counterparts on how subsequent collaboration might be structured in a way that respects the independence and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but recommended that negotiations should continue since much of the country's HIV programmes depended on international support.
"Where specific concerns exist, such as those involving information security or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," the group said.
The situation emphasises the continuing tensions between receiving much-needed international aid and protecting a country's data in an ever more interconnected world.